Helius Medical Technologies Inc. (NASDAQ: HSDT) is 39.22% higher on its value in year-to-date trading and has touched a low of $8.72 and a high of $51.45 in the current 52-week trading range. The HSDT stock was last observed hovering at around $11.23 in the last trading session, with the day’s gains setting it 7.12% off its average median price target of $350.00 for the next 12 months. It is also 94.76% off the consensus price target high of $350.00 offered by 1 analysts, but current levels are 94.76% higher than the price target low of $350.00 for the same period.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Currently trading at $18.35, the stock is 30.54% and 30.99% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.36 million and changing 63.40% at the moment leaves the stock 20.37% off its SMA200. HSDT registered -41.67% loss for a year compared to 6-month loss of 0.84%. The firm has a 50-day simple moving average (SMA 50) of $13.99 and a 200-day simple moving average (SMA200) of $15.43.
The stock witnessed a 21.98% gain in the last 1 month and extending the period to 3 months gives it a 32.90%, and is 28.50% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 50.18% over the week and 17.70% over the month.
Helius Medical Technologies Inc. (HSDT) has around 19 employees, a market worth around $1.06B and $0.60M in sales. Distance from 52-week low is 110.56% and -64.33% from its 52-week high. The company has generated returns on investments over the last 12 months (-413.70%).
Helius Medical Technologies Inc. (HSDT) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Helius Medical Technologies Inc. (HSDT) is a “Hold”. 1 analysts offering their recommendations for the stock, where 1 rate it as a Hold and 0 think it is a “Overweight”. 0 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
Helius Medical Technologies Inc. is expected to release its quarterly report on 05/13/2021 and quarterly earnings per share for the current quarter are estimated at $0.The EPS is expected to grow by 70.50% this year.
Helius Medical Technologies Inc. (HSDT) Top Institutional Holders
The shares outstanding are 40.62M, and float is at 35.81M with Short Float at 2.52%.
The top institutional shareholder in the company is Rovida Advisors Inc. with over 36933.0 shares valued at $0.5 million. The investor’s holdings represent 0.07% of the HSDT Shares outstanding. As of Sep 29, 2020, the second largest holder is Renaissance Technologies, LLC with 29802.0 shares valued at $0.4 million to account for 0.06% of the shares outstanding. The other top investors are Vanguard Group, Inc. (The) which holds 17328.0 shares representing 0.03% and valued at over $0.23 million, while Isthmus Partners LLC holds 0.01% of the shares totaling 5852.0 with a market value of $79244.0.